Asymptomatic pulmonary cryptococcosis in solid organ transplantation: Report of four cases and review of the literature

Transplant Infectious Disease

Volumn 5, Issue 3, 2003, Pages 140-143

  Mueller, N J ^a   Fishman, Jay A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Asymptomatic; Cryptococcosis; Immunosuppression; Solid organ transplantation

Indexed keywords

AMPHOTERICIN B; ANTIGEN; AZATHIOPRINE; CALCINEURIN INHIBITOR; CRYPTOCOCCUS ANTIGEN; CYCLOSPORIN; FLUCONAZOLE; FLUCYTOSINE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; BINDING SITE; CASE REPORT; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LUNG BIOPSY; LUNG DISEASE; LUNG RESECTION; MALE; MICROBIOLOGICAL EXAMINATION; MYCOSIS; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYMPTOMATOLOGY; SYSTEMIC DISEASE; THORAX RADIOGRAPHY; TISSUE DISTRIBUTION;

ADULT; CRYPTOCOCCOSIS; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY; KIDNEY TRANSPLANTATION; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED;

EID: 0242291866     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3062.2003.00026.x     Document Type: Review

References (11)

1. VILCHEZ RA, LINDEN P, LACOMIS J, COSTELLO P, FUNG J, KUSNE S. Acute respiratory failure associated with pulmonary cryptococcosis in non-aids patients. Chest 2001: 119: 1865-1869.
2. CASADEVALL A, PERFECT JR. Cryptococccus neoformans. Washington, DC: American Society for Microbiology Press, 1998.
3. PAYA CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993: 16: 677-688.
4. ABERG JA, MUNDY LM, POWDERLY WG. Pulmonary cryptococcosis in patients without HIV infection. Chest 1999: 115: 734-740.
5. HUSAIN S, WAGENER MM, SINGH N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis 2001: 7: 375-381.
6. PAPPAS PG, PERFECT JR, CLOUD GA, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001: 33: 690-699.
7. VILCHEZ RA, FUNG J, KUSNE S. Cryptococcosis in organ transplant recipients: an overview. Am J Transplant 2002: 2: 575-580.
8. VILCHEZ RA, IRISH W, LACOMIS J, COSTELLO P, FUNG J, KUSNE S. The clinical epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary care medical center. Medicine (Baltimore) 2001: 80: 308-312.
9. KERKERING TM, DUMA RJ, SHADOMY S. The evolution of pulmonary cryptococcosis: clinical implications from a study of 41 patients with and without compromising host factors. Ann Intern Med 1981: 94: 611-616.
10. ODOM A, DEL POETA M, PERFECT J, HEITMAN J. The immunosuppressant FK506 and its nonimmunosuppressive analog L- 685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. Antimicrob Agents Chemother 1997: 41: 156-161.
11. SAAG MS, GRAYBILL RJ, LARSEN RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000: 30: 710-718.